Vutrisiran sodium is a liver-directed, investigational, small interfering ribonucleic acid (siRNA) agent. Vutrisiran sodium can be used for transthyretin (TTR)-mediated amyloidosis research[1].
Molecular Weight:
17311.72
Purity:
96.37
Formula:
C530H671F9N171Na44O323P43S6
Target:
Small Interfering RNA (siRNA)
Application Notes:
Oligonucleotides
* VAT and and shipping costs not included. Errors and price changes excepted